#Medsky🧪 #oncosky #pharmasky #Cancerimmunotherapy Properties of @fda.gov approved small molecule protein kinase inhibitors: A 2024 update & Targeted Drug Therapy for NSCLC .
www.sciencedirect.com/science/arti...

#Medsky🧪 #oncosky ICIs are widely used for #cancerimmunotherapy but only a fraction of patients respond & gut bacteria impact the efficacy of ICIs in fighting tumors outside of the gut. Certain strains of commensal #gutbacteria promote antitumor responses to ICIs …

#Medsky🧪 #IDsky #oncosky #immunosky #publichealth The advent of mRNA vaccines has revolutionized prophylactic & therapeutic strategies across multiple disease areas, from #infectiousdiseases to #cancerimmunotherapy. While highly effective in protecting against #

MedSky🧪 #Immunotherapy #Gutmicrobiome & #Cancerimmunotherapy The #gutmicrobiota influences anti-tumor #immunity & can induce or inhibit response to #immunecheckpointinhibitors

MedSky🧪#CancerResearch #Cancerimmunotherapy the intratumoral #microbiota signatures vary between #neoadjuvantchemotherapy- #Immunotherapy (NACI) responders & nonresponders among patients with ESCC. The responders contained an abundance of tumor-resident Streptococcus compared with nonresponders.

#MedSky🧪#Cancerimmunotherapy #Cancerbiology CD8+ #Tcells are end effectors of #cancerimmunity. Most forms of effective #cancerimmunotherapy involve CD8+ T cell effector function.